Location History:
- Emeryville, CA (US) (2011)
- Berkeley, CA (US) (2003 - 2012)
Company Filing History:
Years Active: 2003-2012
Title: Greg Harrowe: Innovator in Cancer Research
Introduction
Greg Harrowe is a notable inventor based in Berkeley, CA (US), recognized for his contributions to cancer research. He holds a total of 5 patents that focus on understanding and treating cancer, particularly breast cancer. His work has significant implications for diagnostic and therapeutic methods in oncology.
Latest Patents
One of his latest patents involves genes that are differentially expressed in breast cancer. This patent describes a polynucleotide sequence associated with the metastatic potential of cancer cells, especially breast cancer cells. The methods provided allow for determining the risk of metastasis by analyzing whether a tumor tissue sample expresses a specific polypeptide or mRNA. Additionally, therapeutic methods and compositions are included in this patent.
Another significant patent by Harrowe is related to the HX2004-6 polypeptide expressed in cancerous cells. This invention provides polynucleotides and polypeptides that are differentially expressed in cancer cells. These polynucleotides are valuable for various diagnostic and therapeutic methods, including methods aimed at reducing the growth of cancer cells.
Career Highlights
Throughout his career, Greg Harrowe has worked with prominent companies in the biotechnology and pharmaceutical sectors. Notably, he has been associated with Novartis Vaccines & Diagnostics and Chiron Corporation. His experience in these organizations has contributed to his expertise in cancer research and innovation.
Collaborations
Harrowe has collaborated with several professionals in his field, including Joerg Kaufmann and Christoph Reinhard. These collaborations have likely enhanced his research and development efforts in cancer diagnostics and therapeutics.
Conclusion
Greg Harrowe's innovative work in cancer research, particularly through his patents, showcases his commitment to advancing medical science. His contributions are vital for improving cancer diagnosis and treatment options.